Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Aug 9;40(10):1401-1408.
doi: 10.2337/dc17-0885. Online ahead of print.

Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial

Free PMC article

Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial

Adam P Bress et al. Diabetes Care. .
Free PMC article


Objective: To determine whether the effects of intensive (<120 mmHg) compared with standard (<140 mmHg) systolic blood pressure (SBP) treatment are different among those with prediabetes versus those with fasting normoglycemia at baseline in the Systolic Blood Pressure Intervention Trial (SPRINT).

Research design and methods: This was a post hoc analysis of SPRINT. SPRINT participants were categorized by prediabetes status, defined as baseline fasting serum glucose ≥100 mg/dL versus those with normoglycemia (fasting serum glucose <100 mg/dL). The primary outcome was a composite of myocardial infarction, acute coronary syndrome not resulting in myocardial infarction, stroke, acute decompensated heart failure, or death from cardiovascular causes. Cox regression was used to calculate hazard ratios for study outcomes with intensive compared with standard SBP treatment among those with prediabetes and normoglycemia.

Results: Among 9,361 participants randomized (age 67.9 ± 9.4 years; 35.5% female), 3,898 and 5,425 had baseline prediabetes and normoglycemia, respectively. After a median follow-up of 3.26 years, the hazard ratio for the primary outcome was 0.69 (95% CI 0.53, 0.89) and 0.83 (95% CI 0.66, 1.03) among those with prediabetes and normoglycemia, respectively (P value for interaction 0.30). For all-cause mortality, the hazard ratio with intensive SBP treatment was 0.77 (95% CI 0.55, 1.06) for prediabetes and 0.71 (95% CI 0.54, 0.94) for normoglycemia (P value for interaction 0.74). Effects of intensive versus standard SBP treatment on prespecified renal outcomes and serious adverse events were similar for prediabetes and normoglycemia (all interaction P > 0.05).

Conclusions: In SPRINT, the beneficial effects of intensive SBP treatment were similar among those with prediabetes and fasting normoglycemia.


Figure 1
Figure 1
Histogram of baseline FSG among those with normoglycemia (A) and prediabetes (B).
Figure 2
Figure 2
Cumulative incidence of the primary outcome (A) and all-cause mortality (B) by treatment arm stratified by those with normoglycemia and prediabetes at baseline.

Comment in

Similar articles

See all similar articles

Cited by 10 articles

  • [Austrian Consensus on High Blood Pressure 2019].
    Weber T, Arbeiter K, Ardelt F, Auer J, Aufricht C, Brandt MC, Dichtl W, Ferrari J, Föger B, Henkel M, Hohenstein-Scheibenecker K, Horn S, Kautzky-Willer A, Kepplinger E, Knoflach M, Koppelstätter C, Mache C, Marschang P, Mayer G, Metzler B, Oberbauer R, Obermair F, Obermayer-Pietsch B, Perl S, Pilz S, Prischl FC, Podczeck-Schweighofer A, Rebhandl E, Rohla M, Roller-Wirnsberger R, Saely CH, Siostrzonek P, Slany J, Stoschitzky K, Waldegger S, Wenzel RR, Weiss T, Wirnsberger G, Winhofer-Stöckl Y, Zweiker D, Zweiker R, Watschinger B; Österreichische Gesellschaft für Hypertensiologie; Österreichische Atherosklerosegesellschaft; Österreichische Diabetes Gesellschaft; Österreichische Gesellschaft für Internistische Angiologie; Österreichische Gesellschaft für Nephrologie; Österreichische Kardiologische Gesellschaft; Österreichische Gesellschaft für Neurologie; Österreichische Schlaganfall-Gesellschaft; Österr. Gesellschaft für Allgemeinmedizin; Österr. Gesellschaft für Geriatrie; Österreichische Gesellschaft für Endokrinologie und Stoffwechsel; Österreichische Gesellschaft für Innere Medizin; Österreichische Gesellschaft für Kinder- und Jugendheilkunde. Weber T, et al. Wien Klin Wochenschr. 2019 Nov;131(Suppl 6):489-590. doi: 10.1007/s00508-019-01565-0. Wien Klin Wochenschr. 2019. PMID: 31792659 German.
  • Cost-Effectiveness and Challenges of Implementing Intensive Blood Pressure Goals and Team-Based Care.
    Derington CG, King JB, Bryant KB, McGee BT, Moran AE, Weintraub WS, Bellows BK, Bress AP. Derington CG, et al. Curr Hypertens Rep. 2019 Nov 7;21(12):91. doi: 10.1007/s11906-019-0996-x. Curr Hypertens Rep. 2019. PMID: 31701259 Free PMC article. Review.
  • Prediabetes and Risk for Cardiovascular Disease by Hypertension Status in Black Adults: The Jackson Heart Study.
    Hubbard D, Colantonio LD, Tanner RM, Carson AP, Sakhuja S, Jaeger BC, Carey RM, Cohen LP, Shimbo D, Butler M, Bertoni AG, Langford AT, Booth JN 3rd, Kalinowski J, Muntner P. Hubbard D, et al. Diabetes Care. 2019 Dec;42(12):2322-2329. doi: 10.2337/dc19-1074. Epub 2019 Oct 7. Diabetes Care. 2019. PMID: 31591089
  • Influence of Prediabetes on the Effects of Intensive Systolic Blood Pressure Control on Kidney Events.
    Rathi N, Whelton PK, Chertow GM, Cushman WC, Cheung AK, Wei G, Boucher R, Kimmel PL, Bress AP, Kramer HJ, Al-Marji C, Greene T, Beddhu S. Rathi N, et al. Am J Hypertens. 2019 Nov 15;32(12):1170-1177. doi: 10.1093/ajh/hpz105. Am J Hypertens. 2019. PMID: 31257407
  • Serious adverse events in patients with target-oriented blood pressure management: a systematic review.
    Frey L, Gravestock I, Pichierri G, Steurer J, Burgstaller JM. Frey L, et al. J Hypertens. 2019 Nov;37(11):2135-2144. doi: 10.1097/HJH.0000000000002176. J Hypertens. 2019. PMID: 31166252 Free PMC article.
See all "Cited by" articles

LinkOut - more resources